Prolactin (PRL) has been shown to be involved in the differentiation and proliferation of numerous tissues, including the prostate gland. Moreover, variations 
INTRODUCTION
Due to the increase in life expectancy, benign prostate hyperplasia and prostate cancer have become very common diseases. Prostate cancer is now the second highest cause of cancerinduced death among men. It has been clearly established that the growth, differentiation and programmed cell death of prostate cells are regulated by androgens [1] . For this reason, the main treatment for prostate tumours consists of cell growth inhibition by suppressing the action or production of endogenous androgens by chemical or surgical castration. This results only in a temporary regression of the disease, since almost all tumours continue to progress.
Therefore, other non-steroid factors or hormones, like prolactin (PRL), are considered to be important for the normal and pathological development of the prostate gland. Indeed, PRL serum levels increase with age, whereas androgen levels decrease, suggesting that the role of PRL in the development of prostate hyperplasia and cancer becomes more important with age. PRL is a polypeptide hormone belonging to the cytokine super-family, produced mainly in the pituitary gland, but is also synthesized by peripheral tissues, such as the mammary or prostate glands. Studies by several groups, including our own, have shown that PRL is one of the non-steroidal factors involved both in prostate cell proliferation [2, 3] and in the development of benign prostate hyperplasia and prostate cancer [4, 5] .
Previous research in our laboratory has demonstrated the crucial role played by Ca 2+ pools in the prostate [6] [7] [8] . Indeed Ca 2+ -homoeostasis modulation is a mechanism common to a number of signal transduction pathways, regulating a wide range of cell phenomena. [Ca 2+ ] cyt (cytosolic Ca 2+ concentration) is known to control numerous cell functions, including contraction, gene expression and proliferation [9] . The maintenance of [Ca 2+ ] ER [calcium concentration within the ER (endoplasmic reticulum)] is another critical factor for cell growth [10] . The ER is a dynamic environment designed perfectly for protein synthesis, post-translational modifications and folding. Moreover, the maintenance of high intraluminal [Ca 2+ ] is essential for these processes [11] . However the role of calcium signalling in PRL signal transduction has yet to be fully elucidated.
In the present study, we show that PRL stimulates the proliferation of PNT1A prostate cells via a mechanism involving the increase in the [Ca 2+ ] ER , due to the over-expression of SERCA 2b (sarcoendoplasmic calcium ATPase 2b). Using siRNA (small interfering RNA) to down-regulate the endogenous SERCA 2b expression in PNT1A cells, we show that a reduction in Ca 2+ -store content leads to a proportional decrease in cell growth. Thus, the present study provides the first direct evidence that SERCA 2b expression and [Ca 2+ ] ER are major players in PRL signal transduction controlling prostate cell growth. Considering the recent evidence of PRL involvement in the aberrant proliferation of prostate tumours, the present results provide a new insight into the mechanisms of the age-related cancer development.
MATERIALS AND METHODS

Cell culture
The immortalized human prostate normal cell line PNT1A obtained from the European Collection and Cell Culture (E.C.A.C.C.) was maintained in culture in RPMI 1640 medium (Life Technologies, Inc.) supplemented with 10 % (v/v) fetal calf serum (Seromed; Poly-Labo, Strasbourg, France) and 5 mM L-glutamine (Sigma) and 1 % (v/v) kanamycin (Sigma). Cells were grown at 37 • C in a humidified 5 % CO 2 /95 % air atmosphere. The medium was replaced every 48 h.
Proliferation assays
The assay medium was the same as that used for culture, but supplemented with 1 % (v/v) fetal calf serum. The 96-well plates (Nunc) had a final volume of 200 µl and 24-well plates (Nunc) had a final volume of 1 ml and were assayed 48 h after seeding. PNT1A cells were cultured for 4 days after treatment with or without reagents, as indicated. The medium was replaced every 48 h. Proliferation was determined with an MTS [3-(4,5- [13] . Ratio imaging measurements of Mag-Fura 2 fluorescence were made using a Quanticell 900 imaging system.
Western blot
Following the treatment with PRL or siRNA, PNT1A cells were lysed with RIPA buffer [1 % (v/v) Triton X-100, 1 % (w/v) Na deoxycholate, 150 mM NaCl and 20 mM sodium or potassium phosphate, pH 7.2] with 5 mM EDTA and anti-protease cocktail (P8340; Sigma) for 30 min on ice. Insoluble material was discarded by centrifugation at 10 000 g for 10 min at 4
• C and the protein concentration was assessed by the bicinchoninic acid method (Pierce). Equal amounts of proteins were subjected to SDS/PAGE (10 or 16 % gels). Finally, the proteins were transferred on to nitrocellulose membranes using a semi-dry electroblotter (Bio-Rad). After the transfer, the membrane was stained with Ponceau Red and the membranes were cut into thin strips (2 mm wide) that were further processed for immuno-detection. The strips were blocked for 30 min at room temperature in TNT buffer (15 mM Tris/HCl, pH 8, 140 mM NaCl and 0.05 % Tween 20) with 5 % (w/v) dried skimmed milk. Following blocking, the membranes were incubated with mouse anti-actin antibody (pan Ab-5, Neomarkers, Fremont, CA, U.S.A.), rabbit anti-PCNA (proliferating cell nuclear antigen) antibody (sc-56S; Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), rabbit anti-SERCA 2b antibody (a gift from Prof. Frank Wuytack, Department of Molecular Cell Biology, Katholieke Universiteit Leuven, Leuven, The Netherlands) or rabbit antibody anticalreticulin (Stressgen Biotechnologies, San Diego, CA, U.S.A.) diluted in TNT with 5 % (w/v) dried skimmed milk (1:500 for anti-actin; 1:1000 for anti-PCNA; 1:5000 for anti-SERCA 2b; or 1:10 000 for anti-calreticulin) for 1 h at room temperature. After thorough washes in TNT buffer, the strips were treated with the corresponding horseradish peroxidase-linked secondary antibodies (anti-mouse AP192P or anti-rabbit AP182P; Chemicon, Temecula, CA, U.S.A.) diluted 1:20 000 for 1 h at room temperature. After several washes in TNT buffer, the strips were processed for chemiluminescent detection using the SuperSignal West Pico chemiluminescent substrate (Pierce), according to the manufacturer's instructions. The blots were finally exposed to X-Omat AR films (Eastman Kodak Company, Rochester, NY, U.S.A.). The intensity of the signals was evaluated by densitometry and semi-quantified using the ratio between the intensity of protein of interest divided by the actin or JAK2 intensity for each experiment. Each experiment presented was repeated at least twice.
Indirect immunofluorescence
PNT1A cells were grown on glass coverslips. After permeabilization with cold (− 20
• C) acetone for 10 min, the cells were blocked with PBS containing 1.2 % gelatine for 30 min at 37
• C and then incubated with anti-PNCA antibody (diluted 1:100 in PBS/gelatine) for 1 h at 37
• C. After thorough washes in PBS/ gelatine, the slides were treated with Alexa Fluor ® 488-labelled secondary antibody (Molecular Probes) diluted in PBS/gelatine (1:4000) for 1 h at room temperature with Evans Blue (1:50 000). After two washes in PBS/gelatine and in PBS, the slides were mounted with Mowiol ® and examined using a confocal microscope (Zeiss LSM 510). The acquisition parameters were identical throughout the whole experiment to allow a comparison of the intensities of the fluorescence levels. The intensity of the signals was directly quantified on the confocal microscope with LSM examiner software (AIM 3.2; Zeiss, Le Pecq, France). Each experiment was repeated at least three times.
Reagents
Human recombinant PRL was provided by Vincent Goffin (Institut National de la Santé et de la Recherche Médicale; Université René Descartes-Paris V, Paris, France) [14] .
Data analysis
The data were analysed using Origin 5.0 (Microcal Software Inc., Northampton, MA, U.S.A.). Results are expressed as means + − S.E.M. Each experiment was repeated at least three times. Statistical analysis was performed using the Student's t test (P < 0.05 considered as significant) and ANOVA tests followed by Tukey-Kramer post-tests.
RESULTS
PNT1A cell growth is stimulated by PRL
PRL stimulates PNT1A cell growth in a dose-dependent manner ( Figure 1A ). PRL (50-1000 ng/ml) increased cell growth after treatment for 4 days, as estimated by MTS assay. The maximum effect was observed at a dose of 100 ng/ml. At this concentration, PRL induced a proliferation increase of 122.2 + − 6.5 % compared with control conditions. We also checked the effect of PRL on the expression of PCNA, a marker of cell proliferation. Western blot analysis ( Figure 1B) showed that PCNA was weakly expressed in PNT1A cells under control conditions. PCNA proteins were overexpressed 2.3-fold in PNT1A cells treated with 100 ng/ml PRL for 24 h (Figure 1B) , corresponding to the maximum effect observed in the proliferation assay. The PRL-induced increase of PCNA expression was confirmed by immunofluoresence ( Figure 1C) . Indeed, in cells treated with 100 ng/ml PRL for 24 h, the number of cells positive for nuclear PCNA were greater in the PRL treated cells (45 %) compared with control cells (22 %). These results were confirmed using another proliferation marker, the nuclear antigen Ki67 (results not shown). ] cyt was observed in cells treated with 100 ng/ml PRL (50.2 + − 1.2 nM). However, the Ca 2+ release from the intracellular stores induced by 1 µM TG in cells treated for 24 h with 100 ng/ml PRL was greater than in control cells ( Figure 2B ). It is important to point out the remarkable similarity between the extent of cell proliferation ( Figure 1A ) and the amplitude of the TG-induced Ca 2+ release from intracellular stores ( Figure 2B ). The maximum amplitude of TG-induced Ca 2+ release (669.2 + − 44.2 nM), corresponding to 156.1 + − 10.3 % of the TG response observed under control conditions (428.8 + − 18.7 nM), was measured in cells with the highest growth rates (treated with 100 ng/ml PRL). This result suggests that there is a close connection between the Ca 2+ -pool content and the proliferation of PNT1A cells. Moreover, 50 µM AG490, Figure 2D ) using the classical protocol to measure the Ca 2+ re-uptake into the ER after inositol triphosphate-induced release [18] 
SERCA 2b protein expression in PNT1A cells is regulated by PRL
We investigated further the effect of PRL on the expression of SERCA proteins known to play an important role in the maintenance of luminal [Ca 2+ ] ER [16] . Moreover, it has been suggested that SERCA proteins regulate cell growth by controlling the expression of growth and transformation of related genes [17] . We therefore investigated the effect of PRL on the expression of three SERCA isoforms: SERCA 2a (the cardiac/slow skeletal muscle isoform), SERCA 2b (the ubiquitously expressed isoform) and SERCA 3. In our experiments, neither SERCA 2a nor SERCA 3 protein expression were detected under control conditions or in PRL-treated cells. However, Western blot analysis showed that SERCA 2b was constitutively expressed in control cells and over-expressed (3.6-fold) in cells treated with 100 ng/ml PRL for 24 h ( Figure 3A) . This PRL-induced up-regulation of SERCA 2b expression in PNT1A cells was likely to be dependent on tyrosine kinase activity. After a brief (3 h) PRL treatment, Western blot analysis showed that JAK2 kinase was more strongly phosphorylated in PRL-treated cells than control cells ( Figure 3C ). When cells were treated with 100 ng/ml PRL in the presence of 50 µM AG490, the JAK2 kinase inhibitor, we did not observe an upregulation of SERCA 2b expression ( Figure 3A) . Treating PNT1A cells with AG490 alone had no effect on SERCA 2b expression under control conditions (results not shown). We also studied expression of the luminal Ca 2+ binding/storage chaperon calreticulin, to confirm that SERCA 2b over-expression was specific to PRL and was not due to the proliferation increase in protein synthesis. We therefore compared the expression of calreticulin in both control and PRL-treated cells, using semi-quantitative Western blot analysis. Over-expression of SERCA 2b induced by PRL treatment did not alter calreticulin expression ( Figure 3B ). Treatment with 50 µM AG490 before the addition of 100 ng/ml PRL had no effect. (C) Western blot analysis of JAK2 and phospho-JAK2 expression. PRL (100 ng/ml) induced the overphosphorylation of this JAK2. CTL, control; PRL, 100 ng/ml PRL; AG490 + PRL, treatment with 50 µM AG490 before the addition of 100 ng/ml PRL. 2b protein was 70 % lower than the control cells ( Figure 4A ), indicating the effectiveness of the siRNA in down-regulating endogenous SERCA 2b expression. Then, we tested the SERCA2a/b siRNA effect on PNT1A proliferation. We observed a 13.6 % reduction in the proliferation of the SiRNA SERCA 2a/b-treated cells compared with control cells (Figure 4B ). The result was also confirmed by Western blot analysis, which shows the down-regulation of PCNA expression in SERCA2a/b siRNA-treated cells ( Figure 4C ).We next investigated whether the Ca 2+ -pool content was modulated in SERCA2a/b siRNA-treated PNT1A cells. The basal [Ca 2+ ] cyt was affected and an increase in [Ca 2+ ] cyt was observed in cells treated with SERCA2a/b siRNA (111.7 + − 10.1 nM) compared with controls (64.9 + − 2.8 nM; Figure 5A ). The Ca 2+ release induced by 1 µM TG in SERCA2a/b siRNAtreated cells was about 52 % lower than that in control cells (Figure 5B) . Because of the higher basal [Ca 2+ ] cyt level, the resulting driving force may reduce the Ca 2+ release in SERCA2a/b siRNAtreated cells. Therefore, these results were confirmed using the direct quantification of luminal [Ca 2+ ] ER ( Figure 5C ). The luminal 
DISCUSSION
It has been established that PRL [3, 19] and its receptors [2, 3, [20] [21] [22] are expressed in the prostate. These findings have provided significant support for the existence of an autocrine/paracrine PRL-loop in prostate cells. Ahonen et al. [23] have shown that PRL was capable of inducing proliferation and survival of prostate epithelial cells in long-term organ culture of rat prostate tissue explants. In addition, Wennbo et al. [24] have reported a dramatic prostate enlargement in prolactin transgenic mice. In our previous studies [5] , we have established that a chronic hyperprolactinaemia, caused by sulpiride, induced an enlargement and an inflammation of the lateral rat prostate. PRL stimulates the proliferation of LNCaP prostate cancer cells [2] . In the present study, we have shown that PRL stimulates the proliferation of the normal SV40 (simian virus 40) immortalized prostate PNT1A cells. Our experiments are consistent with those reported by Janssen et al. [25] , who showed that PRL induced proliferation in LNCaP, DU145 and PC3 cancer cells. These authors also showed that PRL stimulates the proliferation of PC3 cells in a dose-dependent manner. However, the mechanisms by which PRL stimulates prostate cell proliferation are yet to be fully understood. Ca 2+ homoeostasis modulation is involved in a number of signal transduction pathways regulating a wide range of cellular phenomena. [Ca 2+ ] cyt is known to control numerous cell functions, including contraction, gene expression and proliferation [9] . However, it has been documented that Ca 2+ -pools control numerous cell functions, including protein synthesis and cell proliferation [10, 26] , and the maintenance of Ca 2+ levels within the lumen of the ER is critical for cell growth [10] . Indeed, a range of Ca 2+ -binding proteins within the ER lumen are involved in the folding and correct assembly of proteins. The increased effectiveness of these proteins may be the primary reason for growth progression. An alternative or additional possibility is that high [Ca 2+ ] ER may promote important growth-factor-initiated, IP 3 -mediated Ca 2+ signals that are generated through the release of Ca 2+ from the ER and that are essential for cells to progress through the cell-cycle and to maintain growth. We therefore investigated the potential variation in PNT1A Ca 2+ -pool content linked to PRL-increased proliferation. The results of the present study show that PRLinduced proliferation of PNT1A cells is due, at least partially, to [Ca 2+ ] ER increase and SERCA 2b over-expression by the JAK2 pathway. We did not observe any Ca 2+ modifications in the cytoplasm or any modifications in the SERCA 2b activity following rapid PRL treatment (5-10 min). Thus, we suggest that PRL promotes, via the JAK2/Stat5 transduction signal, the transcription of SERCA 2b, which increases the [Ca 2+ ] ER and subsequently cell growth. The intracellular calcium ATPase and the Ca 2+ -pool content have already been closely associated with cell growth and have been shown to be modulated by hormones or growth factors, such as platelet-derived growth factor [27] . We have shown previously that epidermal growth factor modulates prostate cancer LNCaP cell growth and is correlated with intracellular calcium pool content [7] . The rate of cell growth is correlated with an increase in the Ca 2+ -pool filling state, whereas growth-inhibited cells show a reduced Ca 2+ -pool load. In addition, we have demonstrated that insulin growth factor, which increases prostate cancer LNCaP cell growth, induces an increase in [Ca 2+ ] ER and is associated with an over-expression of SERCA 2b [6] . To our knowledge, in the present study, we show for the first time that PRL stimulates cell proliferation via the over-expression of SERCA 2b and the subsequent up-regulation of [Ca 2+ ] ER . To study the consequence of a reduction in [Ca 2+ ] ER on cell growth, and to confirm the involvement of SERCA 2b in PRLinduced proliferation, we used the siRNA to down-regulate SERCA 2b protein expression. The results show that a reduction in Ca 2+ -pool content leads to a proportional decrease in PNT1A cell growth. The correlation between the decrease in growth rate and the Ca 2+ -pool content decrease has already been demonstrated in other cell models. However, only artificial pharmacological agents have been used in these studies. Depletion of the [Ca 2+ ] ER stores by the Ca 2+ -pump-inhibitor TG, or tBHQ [2,5-di-(tert-butyl)-hydroquinone] promotes growth arrest in DDT1MF-2 smooth muscle cells [15] . In a previous study, we have shown that a long-term treatment with ATP leads to a decrease in the intraluminal [Ca 2+ ] ER and induces growth arrest in DU-145 androgen-independent human prostate cancer cells [28] . In the present study, we also found that [Ca 2+ ] cyt in SERCA2a/b siRNA-treated cells was higher than in control cells. This could be due to the reduced Ca 2+ -pool load or to a compensation mechanism for Ca 2+ signalling, via the upregulation of membrane Ca 2+ channels and exchangers [29] . The reduction of SERCA expression by gene silencing is associated with the up-regulation of TRPC4 (transient receptor potential channel 4) and TRPC5 and Na + /Ca 2+ exchanger in cardiac myocytes. In the present study, store deficiency was compensated for by Ca 2+ flux through the plasma membrane. To summarize, the present study has identified and characterized, for the first time, the intracellular Ca 2+ homoeostasis mechanisms involved in PRL regulation of PNT1A prostate cell growth. We have shown that PRL increases the intracellular Ca 2+ -pool in these proliferative cells through the over-expression of the SERCA 2b calcium pump. Using siRNA, we have specifically down-regulated SERCA 2b expression and shown that the intracellular Ca 2+ -pool was proportionally reduced. As a consequence, this reduces the PNT1A cell proliferation. We suggest that [Ca 2+ ] ER exerts a strict control over cell growth and that it is a crucial element in PRL signal transduction.
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